Prenatal Genetic Screening in a Patient With a Balanced Translocation and a Twin Pregnancy
A 36-year-old G2P0111 (one prior termination for a fetus with trisomy 18, one prior live birth) presents at 11 weeks 2 days with a dichorionic diamniotic twin pregnancy. She carries a known balanced reciprocal translocation, 46,XX,t(11;22)(q23;q11.2). Her partner is 38 and healthy with an unremarkable family history. She wants 'every test that exists' and asks whether she can have the cell-free DNA test she read about. She is anxious about the prior trisomy 18 and about the translocation. Nuchal translucency is not yet measured. She asks what the chance is that each twin is affected.
1. How do you counsel her about cell-free DNA screening in twins, and what are the limits given her translocation?
Read the worked answer
Cell-free DNA (cfDNA) screening in twins: it is validated for trisomies 21, 18, and 13 in twin pregnancies, but performance is lower than in singletons, and it cannot distinguish which twin is affected when a high-risk result occurs. It does not screen for structural anomalies, and it is a screening test, not diagnostic. It also does not detect balanced translocations or most unbalanced rearrangements.
Key limitation for her: cfDNA will not assess her translocation. A fetus with an unbalanced product of a t(11;22) may have a normal cfDNA result and still be affected. Therefore cfDNA can be offered as an adjunct for common aneuploidy, but it cannot replace diagnostic testing.
Her prior trisomy 18 increases her baseline risk for aneuploidy recurrence modestly (population risk plus the prior affected pregnancy). She should be offered diagnostic testing - chorionic villus sampling (CVS) at 11–13 weeks or amniocentesis after 15 weeks - with karyotype plus chromosomal microarray (and, given the translocation, parental karyotypes if not already done). In twins, CVS or amnio requires careful sampling of each sac and documentation of which sample belongs to which twin; she should understand the small procedure-related loss rate and the possibility of a discordant result requiring complex decisions.
Counseling points:
- cfDNA is reasonable if she wants early risk information and understands it is not diagnostic.
- Diagnostic testing is the only way to detect unbalanced translocation and to confirm aneuploidy.
- A detailed anatomy scan at 18–20 weeks and fetal echocardiography are recommended regardless.
- Genetic counseling referral is essential - a certified genetic counselor should review the translocation, recurrence risks, and options for future pregnancies (including preimplantation genetic testing).
2. She asks: 'What is the actual chance each twin is affected by the translocation?' How do you answer, and what is the role of the 11;22 translocation specifically?
Read the worked answer
Answering the probability question honestly:
- A carrier of a balanced reciprocal translocation produces a range of gametes: normal, balanced (like the parent), and unbalanced products (duplication/deletion of the translocated segments). The theoretical risk of an unbalanced conception is often quoted as roughly 5–10%, but the actual observed risk depends heavily on the specific chromosomes, the size and gene content of the segments, the sex of the carrier, and prior reproductive history. For many translocations the viable unbalanced risk is in the low single digits to ~10%.
- Each twin is an independent conception, so each has its own risk; the chance that both are affected is the product (much lower), and the chance at least one is affected is roughly double the per-twin risk. This is a common source of confusion and should be explained explicitly.
- Her prior trisomy 18 is a separate, age-related aneuploidy event and does not change the translocation risk, but it does raise her baseline aneuploidy risk.
The t(11;22)(q23;q11.2) specifically: this is the most common recurrent non-Robertsonian translocation in humans and is known to be associated with Emanuel syndrome when inherited in an unbalanced form (supernumerary derivative chromosome 22), characterized by intellectual disability, craniofacial anomalies, cardiac defects, and other findings. This makes the counseling more concrete: an unbalanced conception is not merely a theoretical concern but carries a recognizable syndrome. Refer to genetics for precise, individualized risk estimates and for discussion of prenatal diagnosis and reproductive options (including PGT-A/PGT-SR and gamete donation).
Practical framing: avoid quoting a single number as certainty; give a range, explain the uncertainty, and emphasize that diagnostic testing gives a definitive answer. Document that she understood the options and made an informed choice.